SYK · 10-Q · 2026Q3 · Full report
Balance Sheet and Liquidity
STRYKER CORP · 2026-10-30 · Importance 46 · Surprise 30 · From source text
Cash, cash equivalents, short-term investments and marketable securities totaled $3,271 million at September 30, 2026, down from $4,100 million at December 31, 2025.,Current assets exceeded current liabilities by $7,683 million at September 30, 2026, compared with $6,961 million at December 31, 2025.,Cash, cash equivalents, short-term investments and marketable securities held outside the United States represented approximately 44% of the total at September 30, 2026, versus 20% at December 31, 2025.,Nine-month operating cash flow increased to $3,303 million from $2,901 million, primarily because higher net earnings were partly offset by working-capital changes.
Key facts
- Approximately 44% of Stryker's cash, cash equivalents, short-term investments, and marketable securities were held outside the United States at September 30, 2026, compared with 20% at December 31, 2025. source
- Current assets exceeded current liabilities by $7,683 million at September 30, 2026 and $6,961 million at December 31, 2025. source
- Cash, cash equivalents, short-term investments, and marketable securities totaled $3,271 million at September 30, 2026, compared with $4,100 million at December 31, 2025. source
- Goodwill attributable to Stryker's Peripheral Vascular reporting unit was approximately $3,259 million at September 30, 2026. source
- Operating cash provided was $3,303 million in the nine months, compared with $2,901 million in the prior-year period; the increase primarily reflected higher net earnings, partly offset by working-capital changes. source
- Cash used in investing activities was $1,011 million in the nine months, compared with $4,561 million in the prior-year period. source
- Cash used in financing activities was $2,998 million in the nine months of 2026, while $1,206 million was provided in the prior-year nine months. source
- Prior-year nine-month financing cash provided was primarily driven by issuance proceeds from various senior unsecured notes, partially offset by dividend payments. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.8% | Cash, cash equivalents, short-term investments, and marketable securities totaled $3,271 million at September 30, 2026, compared with… |
| assets | positive | realized | +1.5% | Current assets exceeded current liabilities by $7,683 million at September 30, 2026 and $6,961 million at December 31, 2025. |